Helix BioPharma Market Cap

Helix BioPharma has a market cap or net worth of $29.56 million as of April 23, 2025. Its market cap has decreased by -5.63% in one year.

Market Cap

29.56M

Enterprise Value

28.11M

Revenue

n/a

Ranking

n/a

PE Ratio

n/a

Stock Price

$0.45

Market Cap Chart

Since August 15, 1995, Helix BioPharma's market cap has increased from 6.90M to 29.56M, an increase of 328.60%. That is a compound annual growth rate of 5.02%.

Market Cap History

Date	Market Cap	% Change
Apr 22, 2025	29.56M	-2.53%
Dec 31, 2024	30.32M	-11.99%
Dec 29, 2023	34.45M	8.43%
Dec 30, 2022	31.77M	-5.92%
Dec 31, 2021	33.77M	-36.31%
Dec 31, 2020	53.03M	-58.92%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
SS Innovations International	1.69B
Endo Inc.	1.63B
Nika Pharmaceuticals	1.02B
Veradigm	704.15M
Northwest Biotherapeutics	489.55M
Elite Pharmaceuticals	449.74M
Glass House Brands	419.36M
CytoDyn	251.42M

Market Cap Rankings